Atrial myocarditis in a patient with Takayasu arteritis


Cite item

Full Text

Abstract

Takayasu arteritis belongs to the group of systemic vasculitis with a predominant lesion of large - caliber vessels and the development of stenosis of their lumen. In world practice, to establish the diagnosis of arteritis Takayasu apply the criteria proposed by the American College of rheumatologists. Currently, there are no randomized clinical trials related to the disease, and the diagnosis and treatment of patients are based on a number of small studies, a series of clinical cases and expert opinion. The described clinical observation of a patient with Takayasu arteritis is of interest in connection with the detected atrial myocarditis during MRI diagnosis of the heart with contrast, which allows us to discuss the feasibility of this imaging technique in complex and doubtful cases.

About the authors

A. A Safiullina

National Medical Research Center of Cardiology; Russian Medical Academy of Continuous Professional Education

Email: a_safiulina@mail.ru
к.м.н., н.с. отд. заболеваний миокарда и сердечной недостаточности НИИ кардиологии им. А.Л. Мясникова ФГБУ «НМИЦ кардиологии»; тел.: +7(495)414-66-69; e-mail: asafiulina@mail.ru; ORCID: 0000-0003-3483-4698 Moscow, Russia

T. M Uskach

National Medical Research Center of Cardiology; Russian Medical Academy of Continuous Professional Education

д.м.н., в.н.с. отд. заболеваний миокарда и сердечной недостаточности НИИ кардиологии им. А.Л. Мясникова ФГБУ «НМИЦ кардиологии», проф. каф. кардиологии ФГБУ ДПО «РМАНПО» Moscow, Russia

I. V Zhirov

National Medical Research Center of Cardiology; Russian Medical Academy of Continuous Professional Education

д.м.н., в.н.с. отд. заболеваний миокарда и сердечной недостаточности НИИ кардиологии им. А.Л. Мясникова ФГБУ «НМИЦ кардиологии», проф. каф. кардиологии ФГБУ ДПО «РМАНПО» Moscow, Russia

O. A Pogorelova

National Medical Research Center of Cardiology

к.м.н., с.н.с. отд. ультразвуковых методов исследования НИИ кардиологии им. А.Л. Мясникова ФГБУ «НМИЦ кардиологии» Moscow, Russia

O. V Stukalova

National Medical Research Center of Cardiology; Russian Medical Academy of Continuous Professional Education

к.м.н., с.н.с. отд. томографии НИИ кардиологии им. А.Л. Мясникова ФГБУ «НМИЦ кардиологии», доц. каф. кардиологии ФГБУ ДПО «РМАНПО» Moscow, Russia

S. A Gaman

National Medical Research Center of Cardiology

к.м.н., н.с. отд. томографии НИИ кардиологии им. А.Л. Мясникова ФГБУ «НМИЦ кардиологии» Moscow, Russia

V. V Gramovich

National Medical Research Center of Cardiology

к.м.н., с.н.с. отд. легочной гипертензии и заболеваний сердца НИИ кардиологии им А.Л. Мясникова ФГБУ «НМИЦ кардиологии» Moscow, Russia

P. I Novikov

Sechenov First Moscow State Medical University (Sechenov University)

к.м.н., в.н.с. ФГБОУ ВО «Первый МГМУ им. И.М. Сеченова» Moscow, Russia

S. N Tereshchenko

National Medical Research Center of Cardiology; Russian Medical Academy of Continuous Professional Education

д.м.н., проф., первый заместитель генерального директора ФГБУ «НМИЦ кардиологии», руководитель отд. заболеваний миокарда и сердечной недостаточности НИИ кардиологии им. А.Л. Мясникова, зав. каф. кардиологии ФГБУ ДПО «РМАНПО» Moscow, Russia

References

  1. Sugiyama K, Ijiri S, Tagawa S, Shimizu K. Takayasu disease on the centenary of its discovery. Jpn J Ophthalmol. 2009;53:81-91. doi: 10.1007/s10384-009-0650-2
  2. Takayasu M. A case with peculiar changes of the central retinal vessels. Acta Societatisophthalmologicae Japonicae. Tokyo, 1908. P. 12, 554-5.
  3. Onen F, Akkoc N. Epidemiology of Takayasu arteritis. Presse Med. 2017;46(7-8 Pt 2):197-203. Epub 2017 Jul 26. doi: 10.1016/j.lpm.2017.05.034
  4. Takamura C, Ohhigashi H, Ebana Y, Isobe M. New human leukocyte antigen risk allele in Japanese patients with Takayasu arteritis. Circ J. 2012;76:1697-702. doi: 10.1253/circj.cj-12-0089
  5. González-Galarza F.F, Takeshita L.Y, Santos E.J, Kempson F, Maia M.H, Da Silva A.L, Teles e Silva A.L, Ghattaoraya G.S, Alfirevic A, Jones A.R, et al. Allele frequency net 2015 update: New features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations. Nucleic Acids Res. 2015;43:D784-D788. doi: 10.1093/nar/gku1166
  6. Kothari S.S. Takayasu's arteritis in children - a review. Imag Ped Cardiol. 2001;3(4):4-23. doi: 10.1111/ijcp.12993
  7. Чихладзе Н.М., Сивакова О.А., Чазова И.Е. Клинические проявления поражения сердечно - сосудистой системы при неспецифическом аортоартериите. Системные гипертензии. 2008;(4):22-4.
  8. Pacheco R.L, Latorraca C.O.C, de Souza A.W.S, Pachito D.V, Riera R. Clinical interventions for Takayasu arteritis: A systematic review. Int J Clin Pract. 2017 Nov;71(11). doi: 10.1111/ijcp.12993
  9. Goel R, Danda D, Joseph G, Ravindran R, Kumar S, Jayaseelan V, Jayaseelan L, Bacon P. Longterm outcome of 251 patients with Takayasu arteritis on combination immunosuppressant therapy: single centre experience from a large tertiary care teaching hospital in Southern India. Semin Arthritis Rheum. 2018;47:718-26. doi: 10.1016/j.semarthrit.2017.09.014
  10. Comarmond C, Biard L, Lambert M, Mekinian A, Ferfar Y, Kahn J.E, Benhamou Y, Chiche L, Koskas F, Cluzel P, Hachulla E, Messas E, Resche-Rigon M, Cacoub P, Mirault T, Saadoun D; French Takayasu Network. Long - term outcomes and prognostic factors of complications in Takayasu arteritis: a multicenter study of 318 patients. Circulation. 2017;136:1114-22. doi: 10.1161/CIRCULATIONAHA.116.027094
  11. Schmidt J, Kermani T.A, Bacani A.K, Crowson C.S, Cooper L.T, Matteson E.L, Warrington K.J. Diagnostic features, treatment, and outcomes of Takayasu arteritis in a US cohort of 126 patients. Mayo Clin Proc. 2013;88:822-30. doi: 10.1016/j.mayocp.2013.04.025
  12. Park S.J, Kim H.J, Park H, Hann H.J, Kim K.H, Han S, Kim Y, Ahn H.S. Incidence, prevalence, mortality and causes of death in Takayasu Arteritis in Korea - a nationwide, population - based study. Int J Cardiol. 2017;235:100-4. doi: 10.1016/j.ijcard.2017.04.013
  13. Subramanyan R, Joy J, Balakrishnan K.G. Natural history of aortoarteritis (Takayasu's disease). Circulation. 1989;80:429-37.
  14. Kim H, Barra L. Ischemic complications in Takayasu’s arteritis: A meta - analysis. Semin Arthritis Rheum. 2018 Jun;47(6):900-6. doi: 10.1016/j.semarthrit.2017.11.001
  15. Serra R, Butrico L, Fugetto F, Chibireva M.D, Malva A, De Caridi G, Massara M, Barbetta A, Cannistrà M, de Franciscis S. Updates in Pathophysiology, Diagnosis and Management of Takayasu Arteritis. Ann Vasc Surg. 2016;35:210-25. doi: 10.1016/j.avsg.2016.02.011
  16. Li J, Sun F, Chen Z, Yang Y, Zhao J, Li M, Tian X, Zeng X. The clinical characteristics of Chinese Takayasu’s arteritis patients: A retrospective study of 411 patients over 24 years. Arthritis Res Ther. 2017;19:107. doi: 10.1186/s13075-017-1307-z
  17. Bicakcigil M, Aksu K, Kamali S, Ozbalkan Z, Ates A, Karadag O, Ozer H.T, Seyahi E, Akar S, Onen F, Cefle A, Aydin S.Z, Yilmaz N, Onat A.M, Cobankara V, Tunc E, Ozturk M.A, Fresko I, Karaaslan Y, Akkoc N, Yücel A.E, Kiraz S, Keser G, Inanc M, Direskeneli H. Takayasu’s arteritis in Turkey - clinical and angiographic features of 248 patients. Clin Exp Rheumatol. 2009;27:S59-S64. PMID: 19646348
  18. Soto M.E, Espinola N, Flores-Suarez L.F, Reyes P.A. Takayasu arteritis: Clinical features in 110 Mexican Mestizo patients and cardiovascular impact on survival and prognosis. Clin Exp Rheumatol. 2008;26:S9-S15. PMID: 18799047
  19. Alibaz-Oner F, Direskeneli H. Update on Takayasu’s arteritis. Presse Med. 2015;44:e259-e265. doi: 10.1016/j.lpm.2015.01.015
  20. Li J, Li H, Sun F, Chen Z, Yang Y, Zhao J, Li M, Tian X, Zeng X. Clinical Characteristics of Heart Involvement in Chinese Patients with Takayasu Arteritis. J Rheumatol. 2017;44:1867-74. doi: 10.3899/jrheum.161514
  21. Arend W.P, Michel B.A, Bloch D.A, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990 Aug;33(8):1129-34.
  22. Dejaco C, Ramiro S, Duftner C, Besson F.L, Bley T.A, Blockmans D, Brouwer E, Cimmino M.A, Clark E, Dasgupta B, Diamantopoulos A.P, Direskeneli H, Iagnocco A, Klink T, Neill L, Ponte C, Salvarani C, Slart R.H.J.A, Whitlock M, Schmidt W.A. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis. 2018 May;77(5):636-43. doi: 10.1136/annrheumdis-2017-212649
  23. Hata A, Noda M, Moriwaki R, Numano F. Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol. 1996;54(l):S155-63. PMID: 9119518
  24. Perera A.H, Mason J.C, Wolfe J.H. Takayasu Arteritis: Criteria for Surgical Intervention Should Not Be Ignored. Int J Vasc Med. 2013. doi: 10.1155/2013/618910
  25. Desai M.Y, Stone J.H, Foo T.K, Hellmann D.B, Lima J.A, Bluemke D.A. Delayed contrast - enhanced MRI of the aortic wall in Takayasu's arteritis: initial experience. AJR Am J Roentgenol. 2005;184:1427-31. doi: 10.2214/ajr.184.5.01841427
  26. Choe Y.H, Han B.K, Koh E.M, Kim D.K, Do Y.S, Lee W.R. Takayasu's arteritis: assessment of disease activity with contrast - enhanced MR imaging. AJR Am J Roentgenol. 2000;175:505-11. doi: 10.2214/ajr.175.2.1750505
  27. Jiang L, Li D, Yan F, Dai X, Li Y, Ma L. Evaluation of Takayasu arteritis activity by delayed contrast - enhanced magnetic resonance imaging. Int J Cardiol. 2012;155(2):262-7. doi: 10.1016/j.ijcard.2010.10.002
  28. Tso E, Flamm S.D, White R.D, Schvartzman P.R, Mascha E, Hoffman G.S. Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum. 2002;46:1634-42. doi: 10.1002/art.10251
  29. Hoffman G.S. Takayasu arteritis: lessons from the American National Institutes of Health experience. Int J Cardiol. 1996;54 Suppl:S99-102.
  30. Mekinian A, Comarmond C, Resche-Rigon M, Mirault T, Kahn J.E, Lambert M, Sibilia J, Néel A, Cohen P, Hie M, Berthier S, Marie I, Lavigne C, Anne Vandenhende M, Muller G, Amoura Z, Devilliers H, Abad S, Hamidou M, Guillevin L, Dhote R, Godeau B, Messas E, Cacoub P, Fain O, Saadoun D; French Takayasu Network.nEfficacy of Biological-Targeted Treatments in Takayasu Arteritis: Multicenter, Retrospective Study of 49 Patients. Circulation. 2015;132:1693-700. doi: 10.1161/CIRCULATIONAHA.114.014321
  31. Ferfar Y, Mirault T, Desbois A.C, Comarmond C, Messas E, Savey L, Domont F, Cacoub P, Saadoun D. Biotherapies in large vessel vasculitis. Autoimmun Rev. 2016;15:544-51. doi: 10.1016/j.autrev.2016.02.012
  32. Langford C.A, Cuthbertson D, Ytterberg S.R, Khalidi N, Monach P.A, Carette S, Seo P, Moreland L.W, Weisman M, Koening C.L. A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu Arteritis. Arthritis Rheum. 2017;9:846-53. doi: 10.1002/art.40037
  33. Nakaoka Y, Isobe M, Takei S, Tanaka Y, Ishii T, Yokota S, Nomura A, Yoshida S, Nishimoto N. Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: Results from a randomised, double - blind, placebo - controlled, phase 3 trial in Japan (the TAKT study). Ann Rheum Dis. 2018;77:348-54. doi: 10.1136/annrheumdis-2017-211878
  34. Chhetri M.K, Pal N.C, Neelakantan C, Chowdhury N.D, Mullick K.C. Endocardial lesion in a case of Takayasu's arteriopathy. Br Heart J. 1970 Nov;32(6):859-62.
  35. Alcalde Ó, Cabrera Gómez S, Vallès Gras E, Benito Villabriga B, Zuccarino F, Martí-Almor J. Rheumatoid Arthritis With Severe Atrial Fibrosis and Multiple Atrial Arrhythmias: Chronic Atrial Myocarditis? Rev Esp Cardiol (Engl Ed). 2018 May;71(5):396-7. doi: 10.1016/j.rec.2017.04.003
  36. Larsen B.T, Maleszewski J.J, Edwards W.D, Cooper L.T.Jr, Sobonya R.E, Thompson V.E, Duckett S.G, Peebles C.R, Simpson I.A, Tazelaar H.D. Atrial giant cell myocarditis: a distinctive clinicopathologic entity. Circulation. 2013 Jan 1;127(1):39-47. doi: 10.1161/CIRCULATIONAHA.112.128900
  37. Mavrogeni S, Manoussakis M.N. Myocarditis and subclavian stenosis in Takayasu arteritis. Int J Cardiol. 2011 Apr 14;148(2):223-4. doi: 10.1016/j.ijcard.2009.05.008
  38. Mavrogeni S, Sfikakis P, Dimitroulas T, Kolovou G, Kitas G.D. Edema and fibrosis imaging by cardiovascular magnetic resonance: how can the experience of Cardiology be best utilized in rheumatological practice? Semin Arthritis Rheum. 2014 Aug;44(1):76-85. doi: 10.1016/j.semarthrit.2014.01.005

Copyright (c) 2019 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies